Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer
Clinical trial NCT04009941 · COMPLETED
Trial details
- NCT number
- NCT04009941
- Sponsor
- Peking University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2020-01-18
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.